Fibromyalgia Treatments Market Research Report nformation by Treatment (Antidepressants, Antiepileptic, Muscle Relaxants, And Others), By End User (Hospital and Clinic), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2034

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

1.1. Market Overview

1.2. Key Findings

1.3. Market Segmentation

1.4. Competitive Landscape

1.5. Challenges and Opportunities

1.6. Future Outlook

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the study

2.2.1. Research Objective

2.2.2. Assumption

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value chain Analysis

5.2. Porter's Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. FIBROMYALGIA TREATMENTS MARKET, BY TREATMENT TYPE (USD BILLION)

6.1. Medications

6.2. Physical Therapy

6.3. Counseling

6.4. Alternative Therapy

6.5. Self-Management Strategies

7. FIBROMYALGIA TREATMENTS MARKET, BY ROUTE OF ADMINISTRATION (USD BILLION)

7.1. Oral

7.2. Topical

7.3. Intravenous

7.4. Injection

8. FIBROMYALGIA TREATMENTS MARKET, BY DISTRIBUTION CHANNEL (USD BILLION)

8.1. Hospital Pharmacy

8.2. Retail Pharmacy

8.3. Online Pharmacy

8.4. Specialty Pharmacy

9. FIBROMYALGIA TREATMENTS MARKET, BY PATIENT DEMOGRAPHICS (USD BILLION)

9.1. Age Groups

9.2. Gender

9.3. Geographic Distribution

10. FIBROMYALGIA TREATMENTS MARKET, BY REGIONAL (USD BILLION)

10.1. North America

10.1.1. US

10.1.2. Canada

10.2. Europe

10.2.1. Germany

10.2.2. UK

10.2.3. France

10.2.4. Russia

10.2.5. Italy

10.2.6. Spain

10.2.7. Rest of Europe

10.3. APAC

10.3.1. China

10.3.2. India

10.3.3. Japan

10.3.4. South Korea

10.3.5. Malaysia

10.3.6. Thailand

10.3.7. Indonesia

10.3.8. Rest of APAC

10.4. South America

10.4.1. Brazil

10.4.2. Mexico

10.4.3. Argentina

10.4.4. Rest of South America

10.5. MEA

10.5.1. GCC Countries

10.5.2. South Africa

10.5.3. Rest of MEA

11. COMPETITIVE LANDSCAPE

11.1. Overview

11.2. Competitive Analysis

11.3. Market share Analysis

11.4. Major Growth Strategy in the Fibromyalgia Treatments Market

11.5. Competitive Benchmarking

11.6. Leading Players in Terms of Number of Developments in the Fibromyalgia Treatments Market

11.7. Key developments and growth strategies

11.7.1. New Product Launch/Service Deployment

11.7.2. Merger & Acquisitions

11.7.3. Joint Ventures

11.8. Major Players Financial Matrix

11.8.1. Sales and Operating Income

11.8.2. Major Players R&D Expenditure. 2023

12. COMPANY PROFILES

12.1. BristolMyers Squibb

12.1.1. Financial Overview

12.1.2. Products Offered

12.1.3. Key Developments

12.1.4. SWOT Analysis

12.1.5. Key Strategies

12.2. Sanofi

12.2.1. Financial Overview

12.2.2. Products Offered

12.2.3. Key Developments

12.2.4. SWOT Analysis

12.2.5. Key Strategies

12.3. Eli Lilly and Company

12.3.1. Financial Overview

12.3.2. Products Offered

12.3.3. Key Developments

12.3.4. SWOT Analysis

12.3.5. Key Strategies

12.4. GSK

12.4.1. Financial Overview

12.4.2. Products Offered

12.4.3. Key Developments

12.4.4. SWOT Analysis

12.4.5. Key Strategies

12.5. Horizon Therapeutics

12.5.1. Financial Overview

12.5.2. Products Offered

12.5.3. Key Developments

12.5.4. SWOT Analysis

12.5.5. Key Strategies

12.6. Boehringer Ingelheim

12.6.1. Financial Overview

12.6.2. Products Offered

12.6.3. Key Developments

12.6.4. SWOT Analysis

12.6.5. Key Strategies

12.7. Teva Pharmaceutical Industries

12.7.1. Financial Overview

12.7.2. Products Offered

12.7.3. Key Developments

12.7.4. SWOT Analysis

12.7.5. Key Strategies

12.8. AbbVie

12.8.1. Financial Overview

12.8.2. Products Offered

12.8.3. Key Developments

12.8.4. SWOT Analysis

12.8.5. Key Strategies

12.9. Amgen

12.9.1. Financial Overview

12.9.2. Products Offered

12.9.3. Key Developments

12.9.4. SWOT Analysis

12.9.5. Key Strategies

12.10. Mylan

12.10.1. Financial Overview

12.10.2. Products Offered

12.10.3. Key Developments

12.10.4. SWOT Analysis

12.10.5. Key Strategies

12.11. Johnson and Johnson

12.11.1. Financial Overview

12.11.2. Products Offered

12.11.3. Key Developments

12.11.4. SWOT Analysis

12.11.5. Key Strategies

12.12. Pfizer

12.12.1. Financial Overview

12.12.2. Products Offered

12.12.3. Key Developments

12.12.4. SWOT Analysis

12.12.5. Key Strategies

12.13. Roche

12.13.1. Financial Overview

12.13.2. Products Offered

12.13.3. Key Developments

12.13.4. SWOT Analysis

12.13.5. Key Strategies

12.14. AstraZeneca

12.14.1. Financial Overview

12.14.2. Products Offered

12.14.3. Key Developments

12.14.4. SWOT Analysis

12.14.5. Key Strategies

12.15. Novartis

12.15.1. Financial Overview

12.15.2. Products Offered

12.15.3. Key Developments

12.15.4. SWOT Analysis

12.15.5. Key Strategies

13. APPENDIX

13.1. References

13.2. Related Reports

LIST OF TABLES

TABLE 1. LIST OF ASSUMPTIONS

TABLE 2. NORTH AMERICA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 3. NORTH AMERICA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 4. NORTH AMERICA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 5. NORTH AMERICA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 6. NORTH AMERICA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 7. US FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 8. US FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 9. US FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 10. US FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 11. US FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 12. CANADA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 13. CANADA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 14. CANADA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 15. CANADA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 16. CANADA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 17. EUROPE FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 18. EUROPE FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 19. EUROPE FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 20. EUROPE FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 21. EUROPE FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 22. GERMANY FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 23. GERMANY FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 24. GERMANY FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 25. GERMANY FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 26. GERMANY FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 27. UK FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 28. UK FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 29. UK FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 30. UK FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 31. UK FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 32. FRANCE FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 33. FRANCE FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 34. FRANCE FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 35. FRANCE FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 36. FRANCE FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 37. RUSSIA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 38. RUSSIA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 39. RUSSIA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 40. RUSSIA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 41. RUSSIA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 42. ITALY FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 43. ITALY FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 44. ITALY FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 45. ITALY FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 46. ITALY FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 47. SPAIN FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 48. SPAIN FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 49. SPAIN FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 50. SPAIN FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 51. SPAIN FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 52. REST OF EUROPE FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 53. REST OF EUROPE FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 54. REST OF EUROPE FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 55. REST OF EUROPE FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 56. REST OF EUROPE FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 57. APAC FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 58. APAC FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 59. APAC FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 60. APAC FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 61. APAC FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 62. CHINA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 63. CHINA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 64. CHINA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 65. CHINA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 66. CHINA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 67. INDIA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 68. INDIA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 69. INDIA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 70. INDIA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 71. INDIA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 72. JAPAN FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 73. JAPAN FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 74. JAPAN FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 75. JAPAN FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 76. JAPAN FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 77. SOUTH KOREA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 78. SOUTH KOREA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 79. SOUTH KOREA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 80. SOUTH KOREA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 81. SOUTH KOREA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 82. MALAYSIA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 83. MALAYSIA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 84. MALAYSIA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 85. MALAYSIA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 86. MALAYSIA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 87. THAILAND FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 88. THAILAND FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 89. THAILAND FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 90. THAILAND FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 91. THAILAND FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 92. INDONESIA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 93. INDONESIA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 94. INDONESIA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 95. INDONESIA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 96. INDONESIA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 97. REST OF APAC FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 98. REST OF APAC FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 99. REST OF APAC FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 100. REST OF APAC FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 101. REST OF APAC FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 102. SOUTH AMERICA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 103. SOUTH AMERICA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 104. SOUTH AMERICA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 105. SOUTH AMERICA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 106. SOUTH AMERICA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 107. BRAZIL FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 108. BRAZIL FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 109. BRAZIL FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 110. BRAZIL FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 111. BRAZIL FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 112. MEXICO FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 113. MEXICO FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 114. MEXICO FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 115. MEXICO FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 116. MEXICO FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 117. ARGENTINA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 118. ARGENTINA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 119. ARGENTINA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 120. ARGENTINA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 121. ARGENTINA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 122. REST OF SOUTH AMERICA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 123. REST OF SOUTH AMERICA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 124. REST OF SOUTH AMERICA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 125. REST OF SOUTH AMERICA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 126. REST OF SOUTH AMERICA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 127. MEA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 128. MEA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 129. MEA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 130. MEA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 131. MEA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 132. GCC COUNTRIES FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 133. GCC COUNTRIES FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 134. GCC COUNTRIES FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 135. GCC COUNTRIES FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 136. GCC COUNTRIES FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 137. SOUTH AFRICA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 138. SOUTH AFRICA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 139. SOUTH AFRICA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 140. SOUTH AFRICA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 141. SOUTH AFRICA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 142. REST OF MEA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2034 (USD BILLIONS)

TABLE 143. REST OF MEA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2034 (USD BILLIONS)

TABLE 144. REST OF MEA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2034 (USD BILLIONS)

TABLE 145. REST OF MEA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT DEMOGRAPHICS, 2019-2034 (USD BILLIONS)

TABLE 146. REST OF MEA FIBROMYALGIA TREATMENTS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2034 (USD BILLIONS)

TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL

TABLE 148. ACQUISITION/PARTNERSHIP

LIST OF FIGURES

FIGURE 1. MARKET SYNOPSIS

FIGURE 2. NORTH AMERICA FIBROMYALGIA TREATMENTS MARKET ANALYSIS

FIGURE 3. US FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY TREATMENT TYPE

FIGURE 4. US FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 5. US FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 6. US FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

FIGURE 7. US FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY REGIONAL

FIGURE 8. CANADA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY TREATMENT TYPE

FIGURE 9. CANADA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 10. CANADA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 11. CANADA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

FIGURE 12. CANADA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY REGIONAL

FIGURE 13. EUROPE FIBROMYALGIA TREATMENTS MARKET ANALYSIS

FIGURE 14. GERMANY FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY TREATMENT TYPE

FIGURE 15. GERMANY FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 16. GERMANY FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 17. GERMANY FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

FIGURE 18. GERMANY FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY REGIONAL

FIGURE 19. UK FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY TREATMENT TYPE

FIGURE 20. UK FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 21. UK FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 22. UK FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

FIGURE 23. UK FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY REGIONAL

FIGURE 24. FRANCE FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY TREATMENT TYPE

FIGURE 25. FRANCE FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 26. FRANCE FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 27. FRANCE FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

FIGURE 28. FRANCE FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY REGIONAL

FIGURE 29. RUSSIA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY TREATMENT TYPE

FIGURE 30. RUSSIA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 31. RUSSIA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 32. RUSSIA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

FIGURE 33. RUSSIA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY REGIONAL

FIGURE 34. ITALY FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY TREATMENT TYPE

FIGURE 35. ITALY FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 36. ITALY FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 37. ITALY FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

FIGURE 38. ITALY FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY REGIONAL

FIGURE 39. SPAIN FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY TREATMENT TYPE

FIGURE 40. SPAIN FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 41. SPAIN FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 42. SPAIN FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

FIGURE 43. SPAIN FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY REGIONAL

FIGURE 44. REST OF EUROPE FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY TREATMENT TYPE

FIGURE 45. REST OF EUROPE FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 46. REST OF EUROPE FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 47. REST OF EUROPE FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

FIGURE 48. REST OF EUROPE FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY REGIONAL

FIGURE 49. APAC FIBROMYALGIA TREATMENTS MARKET ANALYSIS

FIGURE 50. CHINA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY TREATMENT TYPE

FIGURE 51. CHINA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 52. CHINA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 53. CHINA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

FIGURE 54. CHINA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY REGIONAL

FIGURE 55. INDIA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY TREATMENT TYPE

FIGURE 56. INDIA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 57. INDIA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 58. INDIA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

FIGURE 59. INDIA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY REGIONAL

FIGURE 60. JAPAN FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY TREATMENT TYPE

FIGURE 61. JAPAN FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 62. JAPAN FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 63. JAPAN FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

FIGURE 64. JAPAN FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY REGIONAL

FIGURE 65. SOUTH KOREA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY TREATMENT TYPE

FIGURE 66. SOUTH KOREA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 67. SOUTH KOREA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 68. SOUTH KOREA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

FIGURE 69. SOUTH KOREA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY REGIONAL

FIGURE 70. MALAYSIA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY TREATMENT TYPE

FIGURE 71. MALAYSIA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 72. MALAYSIA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 73. MALAYSIA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

FIGURE 74. MALAYSIA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY REGIONAL

FIGURE 75. THAILAND FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY TREATMENT TYPE

FIGURE 76. THAILAND FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 77. THAILAND FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 78. THAILAND FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

FIGURE 79. THAILAND FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY REGIONAL

FIGURE 80. INDONESIA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY TREATMENT TYPE

FIGURE 81. INDONESIA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 82. INDONESIA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 83. INDONESIA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

FIGURE 84. INDONESIA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY REGIONAL

FIGURE 85. REST OF APAC FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY TREATMENT TYPE

FIGURE 86. REST OF APAC FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 87. REST OF APAC FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 88. REST OF APAC FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

FIGURE 89. REST OF APAC FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY REGIONAL

FIGURE 90. SOUTH AMERICA FIBROMYALGIA TREATMENTS MARKET ANALYSIS

FIGURE 91. BRAZIL FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY TREATMENT TYPE

FIGURE 92. BRAZIL FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 93. BRAZIL FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 94. BRAZIL FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

FIGURE 95. BRAZIL FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY REGIONAL

FIGURE 96. MEXICO FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY TREATMENT TYPE

FIGURE 97. MEXICO FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 98. MEXICO FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 99. MEXICO FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

FIGURE 100. MEXICO FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY REGIONAL

FIGURE 101. ARGENTINA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY TREATMENT TYPE

FIGURE 102. ARGENTINA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 103. ARGENTINA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 104. ARGENTINA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

FIGURE 105. ARGENTINA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY REGIONAL

FIGURE 106. REST OF SOUTH AMERICA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY TREATMENT TYPE

FIGURE 107. REST OF SOUTH AMERICA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 108. REST OF SOUTH AMERICA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 109. REST OF SOUTH AMERICA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

FIGURE 110. REST OF SOUTH AMERICA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY REGIONAL

FIGURE 111. MEA FIBROMYALGIA TREATMENTS MARKET ANALYSIS

FIGURE 112. GCC COUNTRIES FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY TREATMENT TYPE

FIGURE 113. GCC COUNTRIES FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 114. GCC COUNTRIES FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 115. GCC COUNTRIES FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

FIGURE 116. GCC COUNTRIES FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY REGIONAL

FIGURE 117. SOUTH AFRICA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY TREATMENT TYPE

FIGURE 118. SOUTH AFRICA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 119. SOUTH AFRICA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 120. SOUTH AFRICA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

FIGURE 121. SOUTH AFRICA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY REGIONAL

FIGURE 122. REST OF MEA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY TREATMENT TYPE

FIGURE 123. REST OF MEA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

FIGURE 124. REST OF MEA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 125. REST OF MEA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

FIGURE 126. REST OF MEA FIBROMYALGIA TREATMENTS MARKET ANALYSIS BY REGIONAL

FIGURE 127. KEY BUYING CRITERIA OF FIBROMYALGIA TREATMENTS MARKET

FIGURE 128. RESEARCH PROCESS OF MRFR

FIGURE 129. DRO ANALYSIS OF FIBROMYALGIA TREATMENTS MARKET

FIGURE 130. DRIVERS IMPACT ANALYSIS: FIBROMYALGIA TREATMENTS MARKET

FIGURE 131. RESTRAINTS IMPACT ANALYSIS: FIBROMYALGIA TREATMENTS MARKET

FIGURE 132. SUPPLY / VALUE CHAIN: FIBROMYALGIA TREATMENTS MARKET

FIGURE 133. FIBROMYALGIA TREATMENTS MARKET, BY TREATMENT TYPE, 2024 (% SHARE)

FIGURE 134. FIBROMYALGIA TREATMENTS MARKET, BY TREATMENT TYPE, 2019 TO 2034 (USD Billions)

FIGURE 135. FIBROMYALGIA TREATMENTS MARKET, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)

FIGURE 136. FIBROMYALGIA TREATMENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019 TO 2034 (USD Billions)

FIGURE 137. FIBROMYALGIA TREATMENTS MARKET, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)

FIGURE 138. FIBROMYALGIA TREATMENTS MARKET, BY DISTRIBUTION CHANNEL, 2019 TO 2034 (USD Billions)

FIGURE 139. FIBROMYALGIA TREATMENTS MARKET, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE)

FIGURE 140. FIBROMYALGIA TREATMENTS MARKET, BY PATIENT DEMOGRAPHICS, 2019 TO 2034 (USD Billions)

FIGURE 141. FIBROMYALGIA TREATMENTS MARKET, BY REGIONAL, 2024 (% SHARE)

FIGURE 142. FIBROMYALGIA TREATMENTS MARKET, BY REGIONAL, 2019 TO 2034 (USD Billions)

FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS